LivaNova (NASDAQ:LIVN) Downgraded by Zacks Research to “Hold”

Posted by Brian Himes on Aug 21st, 2026

LivaNova (NASDAQ:LIVN – Get Free Report) was downgraded by equities researchers at Zacks Research from a “strong-buy” rating to a “hold” rating in a research report issued to clients and investors on Wednesday,Zacks.com reports.

Several other analysts also recently issued reports on the stock. Freedom Capital raised shares of LivaNova to a “hold” rating in a research note on Tuesday, June 30th. Stifel Nicolaus set a $85.00 target price on LivaNova in a research report on Wednesday, August 5th. Weiss Ratings upgraded LivaNova from a “hold (c)” rating to a “hold (c+)” rating in a report on Tuesday. KeyCorp lifted their price target on LivaNova from $83.00 to $92.00 and gave the company an “overweight” rating in a report on Monday, June 22nd. Finally, Mizuho upped their price target on LivaNova from $90.00 to $95.00 and gave the company an “outperform” rating in a research report on Wednesday, July 15th. Six investment analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the company. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $83.50.

Get Our Latest Report on LivaNova

LivaNova Stock Performance

Shares of LIVN opened at $78.21 on Wednesday. LivaNova has a one year low of $48.82 and a one year high of $85.76. The company has a 50-day moving average of $80.56 and a two-hundred day moving average of $71.83. The stock has a market cap of $4.31 billion, a price-to-earnings ratio of 23.14 and a beta of 0.86. The company has a debt-to-equity ratio of 0.22, a current ratio of 1.45 and a quick ratio of 1.21.

LivaNova (NASDAQ:LIVN – Get Free Report) last released its earnings results on Thursday, August 6th. The company reported $1.26 earnings per share for the quarter, topping the consensus estimate of $1.09 by $0.17. The business had revenue of $390.59 million for the quarter, compared to the consensus estimate of $380.50 million. LivaNova had a net margin of 12.82% and a return on equity of 16.35%. The firm’s quarterly revenue was up 10.8% compared to the same quarter last year. During the same period last year, the firm posted $1.05 earnings per share. On average, equities research analysts expect that LivaNova will post 3.77 earnings per share for the current year.

Insiders Place Their Bets

In other news, Director Francesco Bianchi sold 1,800 shares of the firm’s stock in a transaction dated Tuesday, May 26th. The stock was sold at an average price of $75.75, for a total transaction of $136,350.00. Following the completion of the sale, the director directly owned 7,228 shares of the company’s stock, valued at $547,521. This trade represents a 19.94% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. 0.35% of the stock is currently owned by insiders.

Hedge Funds Weigh In On LivaNova

A number of hedge funds have recently added to or reduced their stakes in LIVN. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its stake in LivaNova by 4.0% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 35,497 shares of the company’s stock valued at $1,394,000 after acquiring an additional 1,360 shares during the last quarter. Goldman Sachs Group Inc. raised its holdings in shares of LivaNova by 4.6% during the 1st quarter. Goldman Sachs Group Inc. now owns 814,974 shares of the company’s stock valued at $32,012,000 after purchasing an additional 36,094 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its holdings in LivaNova by 10.0% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 168,863 shares of the company’s stock worth $6,633,000 after purchasing an additional 15,405 shares in the last quarter. Intech Investment Management LLC increased its position in LivaNova by 19.6% during the first quarter. Intech Investment Management LLC now owns 43,879 shares of the company’s stock worth $1,724,000 after buying an additional 7,195 shares during the last quarter. Finally, Strs Ohio bought a new position in LivaNova during the first quarter valued at about $130,000. Institutional investors and hedge funds own 97.64% of the company’s stock.

LivaNova Company Profile

(Get Free Report)

LivaNova plc is a global medical technology company that develops and manufactures products and therapies for the cardiac surgery and neuromodulation markets. Headquartered in London, United Kingdom, and Houston, Texas, LivaNova serves hospitals, clinics and healthcare providers in more than 100 countries. The company’s primary focus lies in advancing patient care through innovations in heart–lung bypass, cardiac preservation, circulatory support and neurostimulation therapies.

The Cardiac Surgery business unit offers a comprehensive portfolio of products used in cardiopulmonary bypass procedures, including oxygenators, heart–lung machines, arterial filters, cannulae and sutureless heart valves.